Genomma Lab Internacional, S.A.B. de C.V., one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced its inclusion in the “Dow Jones Sustainability MILA Pacific Alliance Index” with the highest sustainability standards in Mexico and other countries in Latin America among a select group of companies recognized for excellence in Sustainability and Corporate Governance practices.
Mr. Jorge Luis Brake, Genomma Lab Internacional’s Chief Executive Officer, commented: “We are very pleased to be part of this exceptional list of companies recognized for excellence in corporate practices and for our significant economic, social and environmental contributions to our planet.” He added: “We’re also honored to be the only Latin American pharmaceutical company to be recognized for Sustainability practices by the Dow Jones Sustainability MILA Pacific Alliance Index, as well as the only company within the ‘Pharmaceuticals, Biotechnology and Life Sciences’ category.”
The Dow Jones Sustainability MILA Pacific Alliance Index is the result of an alliance between Standard & Poor’s Dow Jones Index (“S&P DJI”), the International Finance Corporation, RobecoSAM (Part of the S&P DJI), and Mercado Integrado Latinoamericano (MILA).
About Genomma Lab Internacional
Genomma Lab Internacional, S.A.B. de C.V. is one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. Genomma Lab relies on the combination of a successful new product development process, a consumer-oriented marketing, a broad retail distribution network and a low-cost, highly flexible operating model. For more information visit: www.genommalab.com